Design, Synthesis, and Biological Evaluation of Conformationally Constrained cis-Amide Hsp90 Inhibitors

Citations Over TimeTop 24% of 2009 papers

Abstract

Conformationally constrained cis-amide chimeric inhibitors of Hsp90 have been synthesized and evaluated for their Hsp90 inhibitory activity. These new compounds exhibited Hsp90 ATPase inhibition and induced Hsp90-dependent client protein degradation in a dose-dependent manner. Biological data reported herein suggests that amide bond isomerization of geldanamycin derivatives plays an important role in affinity for the heteroprotein complex present in cancer cells.

Related Papers

• → Gambogic Acid, a Natural Product Inhibitor of Hsp90(2011)129 cited
• → HSP90 protects apoptotic cleavage of vimentin in geldanamycin-induced apoptosis(2005)38 cited
• → Heat Shock Proteins: A Potential Anticancer Target(2011)34 cited
• The Hsp90 chaperone as a promising drug target.(2001)
• Heat shock protein90 suppressing apoptosis by preventing the cleavage of Bid in NIH3T3 fibroblasts(2006)